Fisher Asset Management, LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 133 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Fisher Asset Management, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$399,000
-25.4%
105,1250.0%0.00%
-100.0%
Q4 2019$535,000
+0.8%
105,1250.0%0.00%0.0%
Q3 2019$531,000
-18.2%
105,1250.0%0.00%0.0%
Q2 2019$649,000
-30.3%
105,125
-50.1%
0.00%0.0%
Q1 2019$931,000
+110.2%
210,550
+99.7%
0.00%0.0%
Q4 2018$443,000
-32.8%
105,425
+0.3%
0.00%0.0%
Q3 2018$659,000
-37.8%
105,125
-20.3%
0.00%0.0%
Q2 2018$1,060,000
-53.2%
131,861
-56.6%
0.00%
-66.7%
Q1 2018$2,266,000
+25.4%
303,6920.0%0.00%
+50.0%
Q4 2017$1,807,000
-2.5%
303,692
+20.5%
0.00%
-33.3%
Q3 2017$1,854,000
+68.4%
251,930
+55.4%
0.00%
+50.0%
Q2 2017$1,101,000
+19.4%
162,122
+66.1%
0.00%
+100.0%
Q1 2017$922,000
+35.0%
97,632
+23.5%
0.00%0.0%
Q4 2016$683,000
+0.1%
79,028
-26.6%
0.00%0.0%
Q3 2016$682,000
-9.5%
107,663
-23.3%
0.00%0.0%
Q2 2016$754,000
+10.4%
140,361
+0.1%
0.00%0.0%
Q1 2016$683,000
-20.5%
140,1910.0%0.00%
-50.0%
Q4 2015$859,000
+80.5%
140,191
+68.4%
0.00%
+100.0%
Q3 2015$476,00083,2500.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q3 2015
NameSharesValueWeighting ↓
Phocas Financial Corp. 1,033,328$6,376,0000.68%
ARDSLEY ADVISORY PARTNERS LP 650,000$4,011,0000.63%
Worth Venture Partners, LLC 138,357$853,0000.47%
RICE HALL JAMES & ASSOCIATES, LLC 2,242,503$13,836,0000.46%
HIGHLAND CAPITAL MANAGEMENT LP 716,880$4,423,0000.26%
FARALLON CAPITAL MANAGEMENT LLC 5,543,386$34,203,0000.22%
Point72 Asset Management, L.P. 5,858,749$36,148,0000.19%
PINNACLE ASSOCIATES LTD 1,298,723$8,013,0000.19%
Fosun International Ltd 472,580$2,750,0000.18%
J. Goldman & Co LP 400,000$2,468,0000.17%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders